NCT02221388View on ClinicalTrials.gov

Relative Bioavailability of Different Formulations of BI 671800 in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

July 31, 2010

Conditions
Healthy
Interventions
DRUG

BI 671800 HEA, 200 mg tablets

DRUG

BI 671800 HEA EC, 200 mg tablets

DRUG

BI 671800 HEA, 50 mg tablets

DRUG

BI 671800 ED, 100 mg capsules

OTHER

Standard meal

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY